Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages

Kazuko Kobayashi, K. Tada, H. Itabe, T. Ueno, P. H. Liu, A. Tsutsumi, M. Kuwana, T. Yasuda, Y. Shoenfeld, P. G. De Groot, Eiji Matsuura

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Several interpretations have been made regarding the specificity of antiphospholipid antibodies and antibodies against oxidized low-density lipoprotein (oxLDL), but these are still controversial. In the present study, we delineated specificity of these two types of antibodies and analyzed their regulatory effect on oxLDL and/or β2-glycoprotein I (β2GPI) binding to macrophages. Scavenger receptor-mediated binding of oxLDL (or its β2GPI complexes) to macrophages was observed and the binding was partly prevented by β2GPI. The IgG monoclonal anti-β2GPI antibody (WB-CAL-1), which was derived from NZW X BXSB F1 mouse (a model of antiphospholipid syndrome), significantly increased the oxLDL/β2GPI binding to macrophages. In contrast, IgM anti-oxLDL natural antibody, EO6 (derived from apoe-/- mouse), prevented the binding. Different antigenic specificity of these antibodies to oxLDL and its β2GPI complexes was also confirmed in TLC-ligand blot and ELISA. Thus, IgG anti-β2GPI autoantibodies contribute to lipid metabolism (housekeeping of oxLDL by macrophages) whereas IgM natural anti-oxLDL antibodies may protect against atherogenesis. In addition, in vitro data suggest that relatively high dose of intravenous immunoglobulin preparations (mainly contain IgG anti-oxLDL antibodies) might also prevent atherogenesis by inhibiting the oxLDL binding to macrophages.

Original languageEnglish
Pages (from-to)929-938
Number of pages10
JournalLupus
Volume16
Issue number12
DOIs
Publication statusPublished - 2007

Fingerprint

Antiphospholipid Antibodies
Macrophages
Glycoproteins
Antibodies
LDL Lipoproteins
Atherosclerosis
oxidized low density lipoprotein
Scavenger Receptors
Housekeeping
Antiphospholipid Syndrome
Antibody Specificity
Intravenous Immunoglobulins
Apolipoproteins E
Lipid Metabolism
Autoantibodies
Epitopes
Enzyme-Linked Immunosorbent Assay
Ligands

Keywords

  • β-glycoprotein I
  • Anticardiolipin antibody
  • Antiphospholipid syndrome
  • Atherosclerosis
  • Oxidized low-density lipoprotein

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. / Kobayashi, Kazuko; Tada, K.; Itabe, H.; Ueno, T.; Liu, P. H.; Tsutsumi, A.; Kuwana, M.; Yasuda, T.; Shoenfeld, Y.; De Groot, P. G.; Matsuura, Eiji.

In: Lupus, Vol. 16, No. 12, 2007, p. 929-938.

Research output: Contribution to journalArticle

Kobayashi, K, Tada, K, Itabe, H, Ueno, T, Liu, PH, Tsutsumi, A, Kuwana, M, Yasuda, T, Shoenfeld, Y, De Groot, PG & Matsuura, E 2007, 'Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages', Lupus, vol. 16, no. 12, pp. 929-938. https://doi.org/10.1177/0961203307084170
Kobayashi, Kazuko ; Tada, K. ; Itabe, H. ; Ueno, T. ; Liu, P. H. ; Tsutsumi, A. ; Kuwana, M. ; Yasuda, T. ; Shoenfeld, Y. ; De Groot, P. G. ; Matsuura, Eiji. / Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. In: Lupus. 2007 ; Vol. 16, No. 12. pp. 929-938.
@article{6d54e80e4b684eda92ac5b65612869de,
title = "Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages",
abstract = "Several interpretations have been made regarding the specificity of antiphospholipid antibodies and antibodies against oxidized low-density lipoprotein (oxLDL), but these are still controversial. In the present study, we delineated specificity of these two types of antibodies and analyzed their regulatory effect on oxLDL and/or β2-glycoprotein I (β2GPI) binding to macrophages. Scavenger receptor-mediated binding of oxLDL (or its β2GPI complexes) to macrophages was observed and the binding was partly prevented by β2GPI. The IgG monoclonal anti-β2GPI antibody (WB-CAL-1), which was derived from NZW X BXSB F1 mouse (a model of antiphospholipid syndrome), significantly increased the oxLDL/β2GPI binding to macrophages. In contrast, IgM anti-oxLDL natural antibody, EO6 (derived from apoe-/- mouse), prevented the binding. Different antigenic specificity of these antibodies to oxLDL and its β2GPI complexes was also confirmed in TLC-ligand blot and ELISA. Thus, IgG anti-β2GPI autoantibodies contribute to lipid metabolism (housekeeping of oxLDL by macrophages) whereas IgM natural anti-oxLDL antibodies may protect against atherogenesis. In addition, in vitro data suggest that relatively high dose of intravenous immunoglobulin preparations (mainly contain IgG anti-oxLDL antibodies) might also prevent atherogenesis by inhibiting the oxLDL binding to macrophages.",
keywords = "β-glycoprotein I, Anticardiolipin antibody, Antiphospholipid syndrome, Atherosclerosis, Oxidized low-density lipoprotein",
author = "Kazuko Kobayashi and K. Tada and H. Itabe and T. Ueno and Liu, {P. H.} and A. Tsutsumi and M. Kuwana and T. Yasuda and Y. Shoenfeld and {De Groot}, {P. G.} and Eiji Matsuura",
year = "2007",
doi = "10.1177/0961203307084170",
language = "English",
volume = "16",
pages = "929--938",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "12",

}

TY - JOUR

T1 - Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages

AU - Kobayashi, Kazuko

AU - Tada, K.

AU - Itabe, H.

AU - Ueno, T.

AU - Liu, P. H.

AU - Tsutsumi, A.

AU - Kuwana, M.

AU - Yasuda, T.

AU - Shoenfeld, Y.

AU - De Groot, P. G.

AU - Matsuura, Eiji

PY - 2007

Y1 - 2007

N2 - Several interpretations have been made regarding the specificity of antiphospholipid antibodies and antibodies against oxidized low-density lipoprotein (oxLDL), but these are still controversial. In the present study, we delineated specificity of these two types of antibodies and analyzed their regulatory effect on oxLDL and/or β2-glycoprotein I (β2GPI) binding to macrophages. Scavenger receptor-mediated binding of oxLDL (or its β2GPI complexes) to macrophages was observed and the binding was partly prevented by β2GPI. The IgG monoclonal anti-β2GPI antibody (WB-CAL-1), which was derived from NZW X BXSB F1 mouse (a model of antiphospholipid syndrome), significantly increased the oxLDL/β2GPI binding to macrophages. In contrast, IgM anti-oxLDL natural antibody, EO6 (derived from apoe-/- mouse), prevented the binding. Different antigenic specificity of these antibodies to oxLDL and its β2GPI complexes was also confirmed in TLC-ligand blot and ELISA. Thus, IgG anti-β2GPI autoantibodies contribute to lipid metabolism (housekeeping of oxLDL by macrophages) whereas IgM natural anti-oxLDL antibodies may protect against atherogenesis. In addition, in vitro data suggest that relatively high dose of intravenous immunoglobulin preparations (mainly contain IgG anti-oxLDL antibodies) might also prevent atherogenesis by inhibiting the oxLDL binding to macrophages.

AB - Several interpretations have been made regarding the specificity of antiphospholipid antibodies and antibodies against oxidized low-density lipoprotein (oxLDL), but these are still controversial. In the present study, we delineated specificity of these two types of antibodies and analyzed their regulatory effect on oxLDL and/or β2-glycoprotein I (β2GPI) binding to macrophages. Scavenger receptor-mediated binding of oxLDL (or its β2GPI complexes) to macrophages was observed and the binding was partly prevented by β2GPI. The IgG monoclonal anti-β2GPI antibody (WB-CAL-1), which was derived from NZW X BXSB F1 mouse (a model of antiphospholipid syndrome), significantly increased the oxLDL/β2GPI binding to macrophages. In contrast, IgM anti-oxLDL natural antibody, EO6 (derived from apoe-/- mouse), prevented the binding. Different antigenic specificity of these antibodies to oxLDL and its β2GPI complexes was also confirmed in TLC-ligand blot and ELISA. Thus, IgG anti-β2GPI autoantibodies contribute to lipid metabolism (housekeeping of oxLDL by macrophages) whereas IgM natural anti-oxLDL antibodies may protect against atherogenesis. In addition, in vitro data suggest that relatively high dose of intravenous immunoglobulin preparations (mainly contain IgG anti-oxLDL antibodies) might also prevent atherogenesis by inhibiting the oxLDL binding to macrophages.

KW - β-glycoprotein I

KW - Anticardiolipin antibody

KW - Antiphospholipid syndrome

KW - Atherosclerosis

KW - Oxidized low-density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=37649024028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37649024028&partnerID=8YFLogxK

U2 - 10.1177/0961203307084170

DO - 10.1177/0961203307084170

M3 - Article

C2 - 18042586

AN - SCOPUS:37649024028

VL - 16

SP - 929

EP - 938

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 12

ER -